These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35271914)

  • 21. An optimized high-throughput SARS-CoV-2 dual reporter trans-complementation system for antiviral screening in vitro and in vivo.
    Li Y; Tan X; Deng J; Liu X; Liu Q; Zhang Z; Huang X; Shen C; Xu K; Zhou L; Chen Y
    Virol Sin; 2024 Jun; 39(3):447-458. PubMed ID: 38548102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of a DNA-launched SARS-CoV-2 replicon with RNA splicing inhibitor Isoginkgetin.
    Zhang H; Guo H
    J Med Virol; 2024 Mar; 96(3):e29547. PubMed ID: 38511574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery.
    Ge F; Xiong S; Lin FS; Zhang ZP; Zhang XE
    Antiviral Res; 2008 Nov; 80(2):107-13. PubMed ID: 18584889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of A MERS-CoV Replicon Cell Line for Antiviral Screening.
    Chen J; Hu BJ; Zhao K; Luo Y; Lin HF; Shi ZL
    Virol Sin; 2021 Aug; 36(4):730-735. PubMed ID: 33616893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation.
    Wang B; Zhang C; Lei X; Ren L; Zhao Z; Wang J; Huang H
    Virol Sin; 2021 Oct; 36(5):890-900. PubMed ID: 33835389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tricistronic hepatitis C virus subgenomic replicon expressing double transgenes.
    Cheng X; Gao XC; Wang JP; Yang XY; Wang Y; Li BS; Kang FB; Li HJ; Nan YM; Sun DX
    World J Gastroenterol; 2014 Dec; 20(48):18284-95. PubMed ID: 25561795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reverse genetic systems of SARS-CoV-2 for antiviral research.
    Kurhade C; Xie X; Shi PY
    Antiviral Res; 2023 Feb; 210():105486. PubMed ID: 36657881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA.
    Hertzig T; Scandella E; Schelle B; Ziebuhr J; Siddell SG; Ludewig B; Thiel V
    J Gen Virol; 2004 Jun; 85(Pt 6):1717-1725. PubMed ID: 15166457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase.
    Zhao J; Guo S; Yi D; Li Q; Ma L; Zhang Y; Wang J; Li X; Guo F; Lin R; Liang C; Liu Z; Cen S
    Antiviral Res; 2021 Jun; 190():105078. PubMed ID: 33894278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of viral propagation and drug response among SARS-CoV-2 VOCs using replicons capable of recapitulating virion assembly and release.
    Tian L; Liu Q; Pei R; Chen Y; Xu C; Tang J; Sun H; Liu K; Yang Q; Yang L; Li L; Zhang Y; Zhou Y; Shan C; Hu X; Chen X; Wang Y
    Virol Sin; 2022 Oct; 37(5):695-703. PubMed ID: 35781091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reverse genetics systems for SARS-CoV-2.
    Wang W; Peng X; Jin Y; Pan JA; Guo D
    J Med Virol; 2022 Jul; 94(7):3017-3031. PubMed ID: 35324008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Derivation of a novel SARS-coronavirus replicon cell line and its application for anti-SARS drug screening.
    Ge F; Luo Y; Liew PX; Hung E
    Virology; 2007 Mar; 360(1):150-8. PubMed ID: 17098272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and optimization of a high-throughput screening assay for in vitro anti-SARS-CoV-2 activity: Evaluation of 5676 Phase 1 Passed Structures.
    Chiu W; Verschueren L; Van den Eynde C; Buyck C; De Meyer S; Jochmans D; Bojkova D; Ciesek S; Cinatl J; De Jonghe S; Leyssen P; Neyts J; Van Loock M; Van Damme E
    J Med Virol; 2022 Jul; 94(7):3101-3111. PubMed ID: 35229317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay.
    Bai X; Sun H; Wu S; Li Y; Wang L; Hong B
    Front Immunol; 2022; 13():844749. PubMed ID: 35464436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication.
    Ramirez S; Fernandez-Antunez C; Galli A; Underwood A; Pham LV; Ryberg LA; Feng S; Pedersen MS; Mikkelsen LS; Belouzard S; Dubuisson J; Sølund C; Weis N; Gottwein JM; Fahnøe U; Bukh J
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0009721. PubMed ID: 33903110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel cell culture system modeling the SARS-CoV-2 life cycle.
    Ju X; Zhu Y; Wang Y; Li J; Zhang J; Gong M; Ren W; Li S; Zhong J; Zhang L; Zhang QC; Zhang R; Ding Q
    PLoS Pathog; 2021 Mar; 17(3):e1009439. PubMed ID: 33711082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Unique Robust Dual-Promoter-Driven and Dual-Reporter-Expressing SARS-CoV-2 Replicon: Construction and Characterization.
    Liu Y; Li L; Timani KA; He JJ
    Viruses; 2022 May; 14(5):. PubMed ID: 35632716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
    Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase.
    Kato F; Nio Y; Yagasaki K; Suzuki R; Hijikata M; Miura T; Miyazaki I; Tajima S; Lim CK; Saijo M; Takasaki T; Hishiki T
    Antiviral Res; 2019 Dec; 172():104643. PubMed ID: 31678478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
    Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.